New hope for tough lung cancer: experimental combo targets relapsed cases
NCT ID NCT07325136
First seen Jan 10, 2026 · Last updated Jun 08, 2026 · Updated 28 times
Summary
This study tests an experimental drug (BMS-986525) alone or with another drug (nivolumab) in people whose small cell lung cancer has returned or stopped responding to standard chemotherapy. About 240 adults will take part to see if the treatment is safe and shrinks tumors. The goal is to better control the cancer, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Duke Cancer Institute
RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-••••
-
Local Institution - 0001
NOT_YET_RECRUITINGRozzano, Milano, 20089, Italy
Contact
-
Local Institution - 0003
NOT_YET_RECRUITINGCraiova, 200347, Romania
Contact
-
Local Institution - 0009
NOT_YET_RECRUITINGMadrid, 28041, Spain
Contact
-
Local Institution - 0011
NOT_YET_RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
Local Institution - 0018
NOT_YET_RECRUITINGChuo-ku, Tokyo, 104-0045, Japan
Contact
-
Local Institution - 0020
NOT_YET_RECRUITINGHirakata, Osaka, 573-1191, Japan
Contact
-
Local Institution - 0023
NOT_YET_RECRUITINGTimișoara, Timiș County, 300239, Romania
Contact
-
Local Institution - 0026
NOT_YET_RECRUITINGBuffalo, New York, 14263, United States
Contact
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
Contact Phone: •••-•••-••••
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.